Effects of Neural Mobilization on Nerve Conduction Velocity and Neuropathic Symptoms in patients with Diabetic Peripheral Neuropathy

Therapeutic effect and its underlying mechanism of sciatic neural mobilization on diabetic neuropathic pain

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20171215002

Enrollment

120

Registered

2017-12-15

Start date

2016-08-29

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Peripheral Neuropathy

Interventions

Manual technique of Physical therapy ,Vitamin&#45

Experimental Other,Active Comparator Drug

Neural mobilization,Mecomin

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Type 2 Diabetes Mellitus Diabetes Peripheral Neuropathy

Exclusion criteria

Exclusion criteria: pain persistent for 3 days or more over low back and lower extremities in the past 6 months amputation of feet open ulceration over lower extremities history of sciatica or lumbar radiculopathy having received lumbar spine/ knee surgical procedures alcoholism having received chemotherapy in the past year active malignancy on lower extremities

Design outcomes

Primary

Measure	Time frame
Neuropathic symptoms of Diabetic Peripheral Neuropathy before and after 6-week intervention Michigan Neuropathy Screening Instrument	—

Secondary

Measure	Time frame
Nerve Conduction Velocity of lower extremities before and after 6-week intervention NCV studies	—

Countries

Taiwan R.O.C

Contacts

Public ContactChing Hung

Department of Physical Therapy

chhung@mail.ncku.edu.tw886-6-2353535

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026